Titan Biotech Cash Flow Annual

Trade
BSE: 524717 | NSE: - | ISIN: INE150C01011 | Sector: Biotechnology & Drugs
789.70 +24.20 (3.16%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 31.5328.1228.9742.71
Depreciation/ Depletion 3.342.602.372.22
Non- Cash Items 1.531.091.151.94
Changesin Working Capital -15.24-10.63-10.45-27.78
Cashfrom Operating Activities 21.1521.1822.0419.08
Capital Expenditures -20.60-13.17-13.68-4.86
Other Investing Cash Flow Items Total 0.29-7.56-2.76-
Cashfrom Investing Activities -20.30-20.73-16.44-4.86
Financing Cash Flow Items -1.17-0.75-0.87-1.67
Total Cash Dividends Paid -1.49-1.24-1.24-0.83
Issuance( Retirement)of Debt Net -0.21-0.42-1.99-8.11
Cashfrom Financing Activities -2.87-2.40-4.10-10.60
Net Changein Cash -2.02-1.951.513.62
Cash Taxes Paid 7.877.507.1210.88
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts